

Founded in 2018, MOC operates in Health Tech industry. Initially focused on offering comprehensive oncology treatments, the company has evolved to become a leading player in the oncology space in Indi...
Funding stage:
Series B
Last funding:
25/02/2025
Total funding:
$28.09 Mn+
Revenue:
Investors
Employee count:
229
Last 90d
229
Last 90d
Web traffic:
21.09K
21.09K
Last 30d
Last 30d
Glassdoor Rating:
MOC: Cap Table Highlights
A snapshot of cap table and shareholder metrics
- Total Shareholders18
- Latest Filing Date27 March 2025
- Funding Events13
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of MOC
As of 28 March 2025, MOC's equity is held by 16 shareholders, with the top three being Tata Capital Healthcare Fund II, Ashish Joshi, and Vashishth Pankaj Maniar.
Tata Capital Healthcare Fund II holds the largest stake in MOC at 15.1% as of 28 March 2025.
As of 28 March 2025, founders collectively hold 41.1% equity in MOC.
As of 28 March 2025, investors collectively hold 27.0% equity in MOC.
MOC's ESOP pool stands at 3.6% of total equity as of 28 March 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links